<DOC>
	<DOC>NCT02138396</DOC>
	<brief_summary>The objective of this study is to compare the rate of absorption and bioavailability of fentanyl sublingual spray 400 mcg to fentanyl citrate 100 mcg by intramuscular injection.</brief_summary>
	<brief_title>Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions</brief_title>
	<detailed_description />
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Meets protocolspecified criteria for qualification and contraception Good access to veins on both sides Willing and able to remain confined in the study unit for the entire duration of each treatment period and comply with restrictions related food, drink and medications Voluntarily consents to participate and provides written informed consent prior to any protocolspecific procedures Intolerance to venipuncture or injections Presence or history of oral disease, irritation or piercings Allergy or adverse response to fentanyl, naltrexone, or related drugs Tattoos, scarring, or other skin abnormality at planned injection sites History or current use of overthecounter medications, dietary supplements, or drugs (including nicotine and alcohol) outside protocolspecified parameters Signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise: 1) the safety or wellbeing of the participant or study staff; 2) the safety or wellbeing of the participant's offspring (such as through pregnancy or breastfeeding); 3) the analysis of results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>